Involvement of catecholamines in the effect of fasting on hepatic endothelial lipase activity in the rat.
The effect of fasting on hepatic endothelial lipase activity in the liver of adult rats was investigated. We found that, both in male and female rats, fasting produced a progressive decrease of the hepatic endothelial lipase activity. Upon refeeding, the activity returned to control values in 48 h. In isolated livers from fed male rats, a sharp peak of hepatic endothelial lipase activity appeared in the perfusate upon heparin addition. It accounted for 75% of the total activity (heparin-released + residual) of the tissue. Fasting (24 h) decreased the heparin-releasable activity, and this effect was responsible for most of the decrease found in whole tissue. We suggest that the effect might be due to a decreased synthesis and/or secretion of the enzyme by hepatocytes, since isolated hepatocytes from fasted rats, incubated at 37 C, released 65% less activity to the incubation medium than hepatocytes from fed rats. Adrenaline, but not insulin, glucagon, dexamethasone, epidermal growth factor, or T3, decreased the amount of hepatic endothelial lipase activity released by hepatocytes isolated from fed rats. The effect of adrenaline appears to be mediated by alpha 1-receptors since phenylephrine but not isoprenaline reproduced, and prazosin but not propranolol blocked, the effect of the catecholamine. In the presence of cycloheximide, adrenaline also decreased the amount of activity released. We suggest that, in our incubation conditions (up to 3 h), the hormone affects the posttranslational processing of the enzyme. In vivo administration of prazosin blocked the effect of both noradrenaline and fasting on hepatic endothelial lipase activity in whole liver. Those results suggest that catecholamines are involved in the decreased hepatic endothelial lipase activity found in the liver of fasted rats, and points out the role of these hormones in the acute modulation of an enzyme involved in reverse cholesterol transport.
Peinado-Onsurbe
J
J
Departament de Bioquímica i Fisiologia, Universitat de Barcelona, Spain.
Soler
C
C
Galan
X
X
Poveda
B
B
Soley
M
M
Llobera
M
M
Ramírez
I
I
D000818:Animals; D002395:Catecholamines / Q000502:physiology*; D002469:Cell Separation; D004727:Endothelium / Q000166:cytology / Q000201:enzymology; D005215:Fasting; D006493:Heparin / Q000494:pharmacology; D066298:In Vitro Techniques; D008049:Lipase / Q000378:metabolism*; D008099:Liver / Q000166:cytology / Q000201:enzymology*; D011224:Prazosin / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains
D002395:Catecholamines; D006493:Heparin; D008049:Lipase; D011224:Prazosin